comparemela.com

Latest Breaking News On - Jessica volchok - Page 1 : comparemela.com

Mawi DNA Technologies Receives 510(k) Clearance for iSWAB-Respiratory Tract Sample Collection Media-Extraction Less for SARS-CoV-2

Mawi DNA Technologies (Mawi DNA), a biotechnology company focusing on the development and design of innovative technologies for biosampling, announces that the U.S. Food and Drug Administration (FDA)

Bassam-el-fahmawi
Jessica-volchok
Jerome-david
Linkedin
Drug-administration
Twitter
Business-wire
Omawi
Technologies
Eceives
Clearance
Swab

Ancora Heart Inc. and egnite, Inc. Announce Strategic Partnership to Accelerate Clinical Trial Enrollment for Heart Failure Patients

Ancora Heart Inc. and egnite, Inc. Announce Strategic Partnership to Accelerate Clinical Trial Enrollment for Heart Failure Patients
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Cincinnati
Ohio
United-states
Rachel-stein
Joel-portice
Jessica-volchok
Santa-clara
James-buechele
Aliso-viejo
Christ-health-network
Christ-hospital-health-network
Ganey-guardian

Ancora Heart Appoints Mark Miles as Chief Commercial Officer · BioBuzz

Ancora Heart Appoints Mark Miles as Chief Commercial Officer · BioBuzz
biobuzz.io - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biobuzz.io Daily Mail and Mail on Sunday newspapers.

United-states
Santa-clara
Jeff-closs
Eli-lilly
Jessica-volchok
Linkedin
Execution-in-high-growth-companies
Ancora-heart-inc
Drug-administration
Master-of-business-administration
James-madison-university
Facebook

Ancora Heart Enrolls First Patient in the CORCINCH-HF Study

Press release content from Business Wire. The AP news staff was not involved in its creation. Ancora Heart Enrolls First Patient in the CORCINCH-HF Study January 28, 2021 GMT As the only completely transcatheter procedure to treat the enlarged left ventricle, the AccuCinch® Ventricular Restoration System is a fundamentally different and innovative device-based therapy designed to improve the structure and function of the heart and help bring relief to HF patients who remain symptomatic despite current guideline-directed medical care. (Graphic: Business Wire) As the only completely transcatheter procedure to treat the enlarged left ventricle, the AccuCinch® Ventricular Restoration System is a fundamentally different and innovative device-based therapy designed to improve the structure and function of the heart and help bring relief to HF patients who remain symptomatic despite current guideline-directed medical care. (Graphic: Business Wire)

California
United-states
New-york
Ulrich-jorde
Santa-clara
Jeff-closs
Jasonr-foerst
Jessica-volchok
Valve-program
Linkedin
Ancora-heart-inc
Albert-einstein-college-of-medicine

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.